Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 8/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 6/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.66 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.66 |
| ▸ | TUBB4A | P04350 | 6/20 | 0.63 |
| ▸ | TUBB | P07437 | 6/20 | 0.63 |
| ▸ | TUBA3C | P0DPH7 | 6/20 | 0.63 |
| ▸ | TUBA1B | P68363 | 6/20 | 0.63 |
| ▸ | TUBA4A | P68366 | 6/20 | 0.63 |
| ▸ | TUBB4B | P68371 | 6/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Albendazole SCHEMBL31704207 | 1.00 | LMNA (1.00) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL5502364 | 0.96 | LMNA (0.91) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL29612190 | 0.92 | LMNA (0.85) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| SCHEMBL7258034 | 0.91 | LMNA (0.83) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL44682 | 0.91 | LMNA (0.83) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL7969988 | 0.91 | LMNA (0.83) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL29409236 | 0.91 | LMNA (0.83) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL28582887 | 0.89 | LMNA (0.81) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL28958723 | 0.89 | LMNA (0.81) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| SCHEMBL18142126 | 0.88 | LMNA (0.78) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3046 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382291-A1 | SUBSTITUTED PYRROLO[2,3-b]PYRIDINES FOR SUPPRESSING TOXIC ENDOPLASMIC RETICULUM STRESS | UNIV COLUMBIA (US) | 2025-12-18 | — | — | US | claimed |
| US-20250352518-A1 | A BENZIMIDAZOLE COMPOUND WITH ANTIHELMINTHIC ACTIVITY FOR USE IN REVERSING, ARRESTING OR SLOWING DOWN CELLULAR AGEING IN A VERTEBRATE SUBJECT | RAVAN BIO LIMITED (GB) | 2025-11-20 | — | — | US | claimed |
| CN-119876411-A | Haemonchus contortus albendazole drug resistance detection primer, probe and detection method | 内蒙古农业大学 | 2025-04-25 | — | — | CN | claimed |
| EP-4539808-A1 | A BENZIMIDAZOLE COMPOUND WITH ANTIHELMINTHIC ACTIVITY FOR USE IN REVERSING, ARRESTING OR SLOWING DOWN CELLULAR AGEING IN A VERTEBRATE SUBJECT | Ravan Bio Limited (GB) | 2025-04-23 | — | — | EP | claimed |
| CN-119351090-A | Fluorescent probe synthesized by using expired medicine and preparation method and application thereof | 昆明市延安医院(昆明市干部疗养院) | 2025-01-24 | — | — | CN | claimed |
| WO-2024264013-A1 | BIOAVAILABILITY ENHANCING IONIC LIQUID FORMULATIONS AND USES THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-12-26 | — | — | WO | claimed |
| EP-4473964-A1 | COMPOSITION COMPRISING BETA BLOCKER AND CHOLINESTERASE INHIBITOR FOR TREATMENT OF NEURODEGENERATIVE DISEASE | Dr.Noah Biotech Inc. (KR) | 2024-12-11 | — | — | EP | claimed |
| US-20240390364-A1 | Novel Pyridine Compositions and their use in methods for preventing or treating diseases, disorders and conditions | REID CHRISTOPHER BRIAN (US) | 2024-11-28 | — | — | US | claimed |
| CN-118453635-B | Albendazole ivermectin nano-preparation and preparation method thereof | 中国农业科学院农业环境与可持续发展研究所 | 2024-11-01 | — | — | CN | claimed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | claimed |
| US-5169846-A | Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators | CROOKS MICHAEL J (AU) | 1992-12-08 | — | — | US | claimed |
| EP-0427582-A2 | Non-aqueous micellar solutions of various drugs | Crooks, Michael John (AU) | 1991-05-15 | — | — | EP | claimed |
| CN-86108096-A | Novel stabilizing benzimidazole derivative | — | 1987-07-08 | — | — | CN | claimed |
| US-4643893-A | FOR ADMINISTERING MEDICINE TO ANIMAL RUMEN | C.R.B. VIRBAC S.A. (FR) | 1987-02-17 | — | — | US | claimed |
| EP-0146573-A1 | PHARMACEUTICAL COMPOSITIONS WITH ANTHELMINTIC ACTIVITY, DOSAGE UNITS THEREOF AND METHOD FOR TREATING HELMINTHIASIS IN ANIMALS | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-07-03 | — | — | EP | claimed |
| WO-1984004677-A1 | PHARMACEUTICAL COMPOSITIONS WITH ANTHELMINTIC ACTIVITY, DOSAGE UNITS THEREOF AND METHOD FOR TREATING HELMINTHIASIS IN ANIMALS | HOECHST AG (DE) | 1984-12-06 | — | — | WO | claimed |
| EP-0059074-B1 | ANTHELMINTIC COMPOSITION AND THE USE THEREOF | SANKYO COMPANY LIMITED (JP) | 1984-10-10 | — | — | EP | claimed |
| US-4468390-A | Anthelmintic composition and the use thereof | SANKYO COMPANY, LIMITED (JP) | 1984-08-28 | — | — | US | claimed |
| EP-0093497-A2 | Anthelmintic treatment | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1983-11-09 | — | — | EP | claimed |
| EP-0059074-A1 | Anthelmintic composition and the use thereof | SANKYO COMPANY LIMITED (JP) | 1982-09-01 | — | — | EP | claimed |